Human Lymphotoxin betaR/TNFRSF3 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF629
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Ser28-Met227
Accession # P36941
Specificity
Clonality
Host
Isotype
Endotoxin Level
Scientific Data Images for Human Lymphotoxin betaR/TNFRSF3 Antibody
Detection of Lymphotoxin betaR/TNFRSF3 by Western Blot
Blocking clathrin-dependent endocytosis enhances activation of canonical NF-kappa B signaling by LT betaR. A549 (a), HEK293T (b, d) and CCD1070Sk (c, d) cells were transfected with siRNAs targeting clathrin (CHC) (two oligonucleotides) along with control, non-targeting siRNAs (two oligonucleotides) or treated with chlorpromazine (CPZ, e-g) along with DMSO, and stimulated or not with Ago for 1 h. Lysates of cells were analyzed by Western blotting with antibodies against the indicated proteins. Graphs show densitometric analysis of abundance of I kappaB alpha, normalized to loading controls (GAPDH or vinculin). Values are presented as a fold change vs unstimulated non-targeting controls – averaged non-targeting controls (AvCtrl) or DMSO, set as 1. Data represent the means ± SEM, n = 3 (a, b, f, g), n = 4 (c, e); ns - P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001 by one sample t test. Tables present the fold change of I kappaB alpha abundance in stimulated vs unstimulated cells (means, n ≥ 3). d HEK293T and CCD1070Sk cells were analyzed with respect to the efficiency of clathrin knock-down. Representative blots are shown. The blots of GAPDH shown in panels b and c are also shown in panel d Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33148272), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of Lymphotoxin betaR/TNFRSF3 by Western Blot
Clathrin and dynamin deficiency reduces activation of the non-canonical NF-kappa B pathway. a-c A549, HEK293T and CCD1070Sk cells were transfected with siRNAs targeting clathrin (CHC) (two oligonucleotides) along with control, non-targeting siRNAs (two oligonucleotides) and stimulated or not with Ago for 1 h. d, f A549 cells were transfected with siRNAs targeting dynamin-1/2 (three combinations of oligonucleotides targeting dynamin-1 and dynamin-2, see Methods) along with non-targeting control (Ctrl) siRNAs (two combinations of oligonucleotides, see Methods) and stimulated or not with Ago for 1 h. e, g A549 cells were treated with dynasore (DYN) or DMSO and stimulated or not with Ago for 1 h. Lysates of cells were analyzed by Western blotting with antibodies against the indicated proteins. Representative blots are shown. Values presented below blots represent the averaged p52/p100/loading control (a-e) or NIK/loading control ratio (f-g) from at least three experiments (normalized to the selected control, set as 1) in cells stimulated with Ago Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33148272), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of Lymphotoxin betaR/TNFRSF3 by Western Blot
Blocking dynamin-dependent endocytosis enhances activation of canonical NF-kappa B signaling by LT betaR. A549 (a), HEK293T (b, d) and CCD1070Sk (c, d) cells were transfected with siRNAs targeting dynamin-1/2 (three combinations of oligonucleotides targeting dynamin-1 and dynamin-2, see Methods) along with non-targeting control (Ctrl) siRNAs (two combinations of oligonucleotides, see Methods) or treated with dynasore (DYN, e-g) along with DMSO, and stimulated or not with Ago for 1 h. Lysates of cells were analyzed by Western blotting with antibodies against the indicated proteins. Graphs show densitometric analysis of abundance of I kappaB alpha, normalized to loading controls (GAPDH or vinculin). Values are presented as a fold change vs unstimulated non-targeting controls – averaged non-targeting controls (AvCtrl) or DMSO, set as 1. Data represent the means ± SEM, n = 3 (b, c, f), n = 4 (a, e, g); ns - P > 0.05; *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001 by one sample t test. Tables present the fold change of I kappaB alpha abundance in stimulated vs unstimulated cells (means, n ≥ 3). d HEK293T and CCD1070Sk cells were analyzed with respect to the efficiency of dynamin knock-down. Representative blots are shown Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/33148272), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human Lymphotoxin betaR/TNFRSF3 Antibody
CyTOF-ready
Flow Cytometry
Sample: Human whole blood monocytes
Inhibition of Cell Growth
Western Blot
Sample: Recombinant Human Lymphotoxin betaR/TNFRSF3 Fc Chimera (Catalog # 629-LR)
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Lymphotoxin beta R/TNFRSF3
Lymphotoxin beta receptor (LT betaR), also known as TNF RIII and TNF R-related protein (TNF Rrp), was originally identified as a transcribed sequence on human chromosome 12p with homology to the TNF receptor superfamily. In the new TNF nomenclature, LT betaR is referred to as TNFRSF3. Human LT betaR cDNA encodes a 435 amino acid (aa) residue type I membrane protein with a putative 30 aa residue signal peptide, a 193 aa residue extracellular domain and a 171 aa residue cytoplasmic domain. The extracellular domain of LT betaR contains four cysteine-rich motif characteristic of the TNF receptor superfamily. The cytoplasmic region of LT betaR share little sequence similarity with other TNF receptor family members, suggesting that different signaling mechanisms may be utilized. LT betaR is expressed in a variety of tissues including visceral and lymphoid tissues. LT betaR is also expressed by cell lines of monocytic, epithelial, and fibroblastic origins but not by T and B lymphocytes. The human and mouse LT betaR share 76% aa sequence homology. The TNF family ligands that have been shown to bind and activate LT betaR include LIGHT (also a ligand for HVEM) and the heterotrimeric lymphotoxin LT alpha1/ beta2 or LT alpha2/ beta1. Depending on the cell type, activation of LT betaR has been shown to induce NF kappaB activation, chemokine production, growth arrest, and apoptosis. In vivo, LT betaR has been shown to play a critical role in controlling cellular immune functions and lymphoid organogenesis.
References
- Zhai, Y. et al. (1998) J. Clin. Invest. 102:1142.
- Rennert, P.D. et al. (1998) Immunity 9:71.
- Degli-Esposti, M.A. et al. (1997) J. Immunol 158:1756.
- Mackay, F. et al. (1996) J. Biol. Chem. 271:8618.
- Crowe, P.D. et al. (1994) Science 264:707.
Long Name
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional Lymphotoxin beta R/TNFRSF3 Products
Product Documents for Human Lymphotoxin betaR/TNFRSF3 Antibody
Product Specific Notices for Human Lymphotoxin betaR/TNFRSF3 Antibody
For research use only